GLIFLOZIN A NEW CLASS FOR TYPE-II DIABETES MELLITUS: AN OVERVIEW

Abstract

Gliflozin drugs is the sodium-glucose co-transporter 2 inhibitor is the newly developed class of oral hypoglycaemic agents used for the treatment of the type-II diabetes mellitus. This class approved by food and drug administration in 2013 for the treatment of diabetes, with a unique mechanism of action. SLGT-2 proteins are macromolecule reabsorb the filtered glucose molecule from (PCT) in the kidney. This class of drugs block SGLT-2 protein from the site of the proximal convoluted tubule (PCT) in the kidney, resulting in prevent reabsorption of a glucose molecule and allow excretion of glucose molecule through urine. By this mechanism, the gliflozins drug lowers the blood glucose level in the body.SGLT-2 inhibitors are the newest class of anti-diabetic drugs grab more attention when it is used in combination with insulin and other anti-diabetic drugs. Gliflozins shows various adverse effect such as ketoacidosis, urinary tract infection, bone fracture, and foot and leg amputation. This article explained pathogenesis and pathophysiology of type-II diabetes mellitus with a detailed mechanism of action of a gliflozin class of drugs. Also, latest gliflozin class drugs introduced and approved are discussed in this review.

Authors and Affiliations

S. S. Tiwari et al.

Keywords

Related Articles

SYNTHESIS OF NOVEL 2-PHENYL-1-BENZOFURAN-3(2H)-ONE DERIVATIVES AS NEW LEADS FOR ANTI-CANCER ACTIVITY

Benzofuranone is a bicyclic ring where a benzene ring fused with a furanone. Synthetic chemistry plays a major in developing a series of potent anti-cancer agents. Bromophenyl acetonitrile was prepared from phenyl aceton...

IN-SILICO MOLECULAR DOCKING ANALYSIS OF ISOLATED HOMOISOFLAVANONES FROM BULBS OF LEDABOURIA REVOLUTA AS GABAA RECEPTOR INHIBITORS

γ-Aminobutyric acid (GABA) is the major inhibitory neurotransmitter in the vertebrate central nervous system (CNS); it activates the GABAA receptors that play a role in epilepsy. Targeting GABAA receptors through specifi...

A NEW ANTIOXIDANT ACTIVE COMPOUND FROM THE ENDOLICHENIC FUNGUS, PENICILLIUM CITRINUM INHABITING THE LICHEN, PARMOTREMA SP.

Context: Endolichenic fungi are the microorganisms living inside the thalli of the lichen and found to be a new source of bioactive secondary metabolites. This is an underutilized source of bioactive compounds and has no...

DISINFECTANTS, REGULATION AND REQUIREMENTS - GLOBAL OVERVIEW

Surface disinfectant is the multi-billion-dollar global industry with continuous growth opportunities linked to advancements in technology and innovations. However, innovations and new advancements do not always reach co...

THE RELATIONSHIP BETWEEN NUTRITIONAL STATUS AND NUTRIENT INTAKE WITH ANEMIA INCIDENCE IN ADOLESCENT GIRLS IN KUPANG INDONESIA

The study aimed to determine the relationship between nutritional status and nutrient intake and the incidence of anemia in adolescent girls in Kupang. It was an observational research with a cross-sectional design. The...

Download PDF file
  • EP ID EP627068
  • DOI 10.13040/IJPSR.0975-8232.10(9).4070-77
  • Views 95
  • Downloads 0

How To Cite

S. S. Tiwari et al. (2019). GLIFLOZIN A NEW CLASS FOR TYPE-II DIABETES MELLITUS: AN OVERVIEW. International Journal of Pharmaceutical Sciences and Research (IJPSR), 10(9), 4070-4077. https://europub.co.uk./articles/-A-627068